These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 36845109)

  • 1. Dysfunction of the noradrenergic system drives inflammation, α-synucleinopathy, and neuronal loss in mouse colon.
    Song S; Tu D; Meng C; Liu J; Wilson B; Wang Q; Shih YI; Gao HM; Hong JS
    Front Immunol; 2023; 14():1083513. PubMed ID: 36845109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opposing effects of β-2 and β-1 adrenergic receptor signaling on neuroinflammation and dopaminergic neuron survival in α-synuclein-mediated neurotoxicity.
    Torrente D; Su EJ; Schielke GP; Warnock M; Mann K; Lawrence DA
    J Neuroinflammation; 2023 Mar; 20(1):56. PubMed ID: 36864439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of Brain Norepinephrine Elicits Neuroinflammation-Mediated Oxidative Injury and Selective Caudo-Rostral Neurodegeneration.
    Song S; Jiang L; Oyarzabal EA; Wilson B; Li Z; Shih YI; Wang Q; Hong JS
    Mol Neurobiol; 2019 Apr; 56(4):2653-2669. PubMed ID: 30051353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic Mild Gut Inflammation Accelerates Brain Neuropathology and Motor Dysfunction in α-Synuclein Mutant Mice.
    Kishimoto Y; Zhu W; Hosoda W; Sen JM; Mattson MP
    Neuromolecular Med; 2019 Sep; 21(3):239-249. PubMed ID: 31079293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice.
    Pavia-Collado R; Cóppola-Segovia V; Miquel-Rio L; Alarcón-Aris D; Rodríguez-Aller R; Torres-López M; Paz V; Ruiz-Bronchal E; Campa L; Artigas F; Montefeltro A; Revilla R; Bortolozzi A
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GV-971 attenuates α-Synuclein aggregation and related pathology.
    Yu Z; Yang Y; Chan RB; Shi M; Stewart T; Huang Y; Liu Z; Lan G; Sheng L; Tian C; Yang D; Zhang J
    CNS Neurosci Ther; 2024 Feb; 30(2):e14393. PubMed ID: 37563872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTEN-Induced Putative Kinase 1 Dysfunction Accelerates Synucleinopathy.
    Nguyen TT; Kim YJ; Lai TT; Nguyen PT; Koh YH; Nguyen LTN; Ma HI; Kim YE
    J Parkinsons Dis; 2022; 12(4):1201-1217. PubMed ID: 35253778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson's disease.
    Kelly LP; Carvey PM; Keshavarzian A; Shannon KM; Shaikh M; Bakay RA; Kordower JH
    Mov Disord; 2014 Jul; 29(8):999-1009. PubMed ID: 24898698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzo(a)pyrene exposure in utero exacerbates Parkinson's Disease (PD)-like α-synucleinopathy in A53T human alpha-synuclein transgenic mice.
    Xu W; Qi Y; Gao Y; Quan H; Li Q; Zhou H; Huang J
    Toxicol Appl Pharmacol; 2021 Sep; 427():115658. PubMed ID: 34332006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholecystokinin and glucagon-like peptide-1 analogues regulate intestinal tight junction, inflammation, dopaminergic neurons and α-synuclein accumulation in the colon of two Parkinson's disease mouse models.
    Su Y; Liu N; Zhang Z; Li H; Ma J; Yuan Y; Shi M; Liu J; Zhao Z; Zhang Z; Holscher C
    Eur J Pharmacol; 2022 Jul; 926():175029. PubMed ID: 35584709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noradrenergic dysfunction accelerates LPS-elicited inflammation-related ascending sequential neurodegeneration and deficits in non-motor/motor functions.
    Song S; Wang Q; Jiang L; Oyarzabal E; Riddick NV; Wilson B; Moy SS; Shih YI; Hong JS
    Brain Behav Immun; 2019 Oct; 81():374-387. PubMed ID: 31247288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine A1 receptor ligands bind to α-synuclein: implications for α-synuclein misfolding and α-synucleinopathy in Parkinson's disease.
    Jakova E; Moutaoufik MT; Lee JS; Babu M; Cayabyab FS
    Transl Neurodegener; 2022 Feb; 11(1):9. PubMed ID: 35139916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrastriatal injection of Parkinson's disease intestine and vagus lysates initiates α-synucleinopathy in rat brain.
    Yang Z; Wang Y; Wei M; Li S; Jia C; Cheng C; Al-Nusaif M; Zhang J; Liu C; Le W
    Cell Death Dis; 2023 Jan; 14(1):4. PubMed ID: 36604420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Norepinephrine depleting toxin DSP-4 and LPS alter gut microbiota and induce neurotoxicity in α-synuclein mutant mice.
    Song S; Liu J; Zhang F; Hong JS
    Sci Rep; 2020 Sep; 10(1):15054. PubMed ID: 32929122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid Induction of Dopaminergic Neuron Loss Accompanied by Lewy Body-Like Inclusions in A53T BAC-SNCA Transgenic Mice.
    Okuda S; Uemura N; Sawamura M; Taguchi T; Ikuno M; Uemura MT; Yamakado H; Takahashi R
    Neurotherapeutics; 2022 Jan; 19(1):289-304. PubMed ID: 34935120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoamine Oxidase-B Inhibition Facilitates α-Synuclein Secretion
    Nakamura Y; Arawaka S; Sato H; Sasaki A; Shigekiyo T; Takahata K; Tsunekawa H; Kato T
    J Neurosci; 2021 Sep; 41(35):7479-7491. PubMed ID: 34290084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathy.
    Earls RH; Menees KB; Chung J; Gutekunst CA; Lee HJ; Hazim MG; Rada B; Wood LB; Lee JK
    Proc Natl Acad Sci U S A; 2020 Jan; 117(3):1762-1771. PubMed ID: 31900358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The involvement of α-synucleinopathy in the disruption of microglial homeostasis contributes to the pathogenesis of Parkinson's disease.
    Miao Y; Meng H
    Cell Commun Signal; 2024 Jan; 22(1):31. PubMed ID: 38216911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of One Engrailed1 Allele Enhances Induced α-Synucleinopathy.
    Chatterjee D; Sanchez DS; Quansah E; Rey NL; George S; Becker K; Madaj Z; Steiner JA; Ma J; Escobar Galvis ML; Kordower JH; Brundin P
    J Parkinsons Dis; 2019; 9(2):315-326. PubMed ID: 30932894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained chemogenetic activation of locus coeruleus norepinephrine neurons promotes dopaminergic neuron survival in synucleinopathy.
    Jovanovic P; Wang Y; Vit JP; Novinbakht E; Morones N; Hogg E; Tagliati M; Riera CE
    PLoS One; 2022; 17(3):e0263074. PubMed ID: 35316276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.